Anthropic and OpenAI Both Report Enterprise AI Spend Shifting From Pilots to Multi-Year Contracts

Enterprise AI purchasing is maturing past the pilot-program stage that characterized 2024 and most of 2025, according to briefings from both Anthropic and OpenAI describing a shift toward multi-year committed-spend contracts rather than the smaller, easily-cancelled proof-of-concept deployments that made up the bulk of early enterprise AI revenue. The shift reflects a purchasing pattern familiar from prior enterprise software cycles: early pilots prove out a use case, and only once ROI is demonstrable internally does procurement commit to the multi-year contract structure that vendors actually want for revenue predictability. The functional areas driving the largest committed contracts are customer service automation, software engineering assistance, and internal knowledge-base search and synthesis — the three categories where enterprise buyers report the clearest, most measurable productivity gain, as opposed to more experimental use cases like autonomous multi-step business process agents, which remain earlier-stage and more pilot-heavy across most enterprise buyers surveyed by industry analysts. The competitive dynamic between labs is shifting accordingly: rather than competing primarily on raw model benchmark performance, both companies are increasingly differentiating on enterprise-specific features — admin controls, audit logging, data residency guarantees, and integration depth with existing enterprise software like Salesforce, ServiceNow, and Microsoft 365 — since large committed-spend buyers weight those operational factors heavily alongside raw model capability once they're past the initial pilot evaluation stage. For enterprise procurement teams, the practical effect is a narrowing of vendor choice at the multi-year contract stage even as the number of viable AI vendors at the pilot stage keeps growing, since committing to a multi-year contract requires confidence in a vendor's roadmap and operational maturity that fewer vendors outside the top two or three labs can currently demonstrate at enterprise scale.